甲状旁腺功能亢进是儿童肾移植同种异体移植物功能障碍的独立危险因素
这项来自欧洲儿童肾移植协作组(CERTAIN)的注册研究纳入16个欧洲国家1210例儿童肾移植患者,分析甲状旁腺激素、钙、磷和25-羟基维生素D与移植物结局的关系。复合终点(移植物丢失或eGFR≤30 ml/min/1.73 m²或较移植后1个月eGFR下降≥50%)在250例移植物中发生(21%)。校正混杂因素后,仅甲状旁腺功能亢进(HR 2.94;95%CI 1.82-4.74)和高磷血症(HR 1.94;95%CI 1.28-2.92)与复合终点相关;边际结构模型显示甲状旁腺功能亢进结果相似(HR 2.74;95%CI 1.71-4.38),而高磷血症不再显著(HR 1.35;95%CI 0.87-2.09)。结论认为甲状旁腺功能亢进是儿童同种异体移植物功能障碍的潜在独立危险因素。
要点
- 儿童肾移植后甲状旁腺功能亢进与移植物功能障碍独立相关(HR 2.94;95%CI 1.82-4.74)。
- 高磷血症在常规Cox模型中与复合终点相关(HR 1.94;95%CI 1.28-2.92),边际结构模型校正后不再显著(HR 1.35;95%CI 0.87-2.09)。
- 复合终点在250例移植物中发生(21%),其中移植物丢失11例(4%)。
核心结论
- 甲状旁腺功能亢进是儿童同种异体移植物功能障碍的潜在独立危险因素。
研究设计与样本
- 来自欧洲儿童肾移植协作组(CERTAIN)的注册研究,纳入1210例患者(61%为男孩),来自16个欧洲国家。
- 于基线、移植后1、3、6、9、12个月及此后每6个月至5年收集数据。
- 对复合终点(移植物丢失或eGFR≤30 ml/min/1.73 m²或较移植后1个月eGFR下降≥50%)进行生存分析,采用常规分层Cox比例风险模型和含时变协变量的边际结构模型分析甲状旁腺激素、钙、磷和25-羟基维生素D与移植物结局的关联。
主要发现
- 复合终点在250例移植物中发生(21%),其中移植物丢失11例(4%)。
- 常规Cox比例风险模型校正潜在混杂因素后,仅甲状旁腺功能亢进(HR 2.94;95%CI 1.82-4.74)和高磷血症(HR 1.94;95%CI 1.28-2.92)与复合终点相关。
- 边际结构模型显示甲状旁腺功能亢进结果相似(HR 2.74;95%CI 1.71-4.38),而高磷血症不再显著(HR 1.35;95%CI 0.87-2.09),提示其与移植物功能障碍的关联可归因于eGFR下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Little is known about the consequences of deranged chronic kidney disease-mineral and bone disorder (CKD-MBD) parameters on kidney allograft function in children. We examined a relationship between these parameters over time and allograft outcome. METHODS: This registry study from the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN) collected data at baseline, months 1, 3, 6, 9, and 12 after transplant; and every 6 months thereafter up to 5 years. Survival analysis for a composite end point of graft loss or estimated glomerular filtration rate (eGFR) ≤30 ml/min per 1.73 m2 or a ≥50% decline from eGFR at month 1 posttransplant was performed. Associations of parathyroid hormone (PTH), calcium, phosphate, and 25-hydroxyvitamin D (25(OH)D) with allograft outcome were investigated using conventional stratified Cox proportional hazards models and further verified with marginal structural models with time-varying covariates. RESULTS: We report on 1210 patients (61% boys) from 16 European countries. The composite end point was reached in 250 grafts (21%), of which 11 (4%) were allograft losses. In the conventional Cox proportional hazards models adjusted for potential confounders, only hyperparathyroidism (hazard ratio [HR], 2.94; 95% confidence interval [CI], 1.82-4.74) and hyperphosphatemia (HR, 1.94; 95% CI, 1.28-2.92) were associated with the composite end point. Marginal structural models showed similar results for hyperparathyroidism (HR, 2.74; 95% CI, 1.71-4.38), whereas hyperphosphatemia was no longer significant (HR, 1.35; 95% CI, 0.87-2.09), suggesting that its association with graft dysfunction can be ascribed to a decline in eGFR. CONCLUSION: Hyperparathyroidism is a potential independent risk factor for allograft dysfunction in children.
引用
- Prytula A, Shroff R, Krupka K, et al. Hyperparathyroidism Is an Independent Risk Factor for Allograft Dysfunction in Pediatric Kidney Transplantation. Kidney Int Rep. 2022. PMID: 36644359. doi:10.1016/j.ekir.2022.10.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。